WAVEWaverley Pharma Inc.

0.0150CAD0.00%Mkt Cap: 589891 $P/E:

Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops PARP-1 Inhibitors for cancer treatment. It also operates a ret…

Key Statistics

Company
Market Cap589.89K $
Enterprise Value3.12M $
Revenue (TTM)906.97K $
Gross Profit374.09K $
Net Income (TTM)-363.56K $
Revenue/Share0.0168 USD
Last Price0.0150 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-10.82
EV/Revenue3.44
P/S0.65
P/B-0.30
EPS (TTM)-0.01
EPS (Forward)
52W Range
0.010017% of range0.0400
52W High0.0400 CAD
52W Low0.0100 CAD
Profitability
Gross Margin38.06%
Oper. Margin-42.78%
EBITDA Margin-31.77%
Profit Margin-36.99%
ROE19.42%
ROA-40.12%
Growth
Revenue Growth-26.60%
Earnings Growth
Cash Flow & Leverage
Operating CF-444.99K $
CapEx (TTM)
FCF Margin-10.22%
FCF Yield-15.71%
Net Debt2.53M $
Net Debt/EBITDA-8.77
Balance Sheet
Debt/Equity-1.34
Current Ratio0.11
Quick Ratio0.02
Book Value/Sh-0.0500 CAD
Cash/Share0.0010 CAD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 CAD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.54.00M
Float13.55M
Insiders74.90%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short39
Short (prev mo.)178
Technical
SMA 500.0187 (-19.8%)
SMA 2000.0174 (-13.9%)
Beta1.15
S&P 52W Chg18.16%
Avg Vol (30d)1.08K
Avg Vol (10d)1.10K
Technical Indicators
RSI (14)38.5
MACD-0.0011
MACD Signal-0.0012
MACD Hist.+0.0001
BB Upper0.0208 CAD
BB Middle0.0147 CAD
BB Lower0.0087 CAD
BB Width82.01%
ATR (14)0.0006 CAD
Vol Ratio (20d)0.00x